News
National Cancer Institute and Gritstone bio team up on vaccine
Gritstone bio – a company focused on developing global vaccinations – has revealed that it has established a clinical trial partnership with the National Cancer Institute (NCI).
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Gritstone bio – a company focused on developing global vaccinations – has revealed that it has established a clinical trial partnership with the National Cancer Institute (NCI).